oncologynews
@oncologynews
Sat, Oct 20, 2018 9:59 PM
Capmatinib plus gefitinib overcomes EGFR resistance in NSCLC -
Capmatinib plus gefitinib overcomes EGFR resistance ...
 https://imgs.plurk.com/Qv0/jqq/WMiZ7PtZOWukMsnWsvpalvenset_lg.jpeg
載入新的回覆